Skip directly to content

11. Globalni skup o hemofiliji – 2.dio: Suvremena razmatranja u liječenju hemofilije

11. Globalni skup o hemofiliji – Sastanak održan u organizaciji neovisnog Upravljačkog povjerenstva  i pod pokroviteljstvom tvrtke Pfizer u razdoblju od 24. do 26. Studenog 2020. godine. Članovi upravljačkog povjerenstva: Gerry Dolan (UK), Jan Astermark (Švedska), Cedrid Hermans (Belgija) i Cristina Catarino (Portugal).

 

Should we still be concerned about inhibitors in 2020?
Jan Astermark (Sweden)
 

 

In 2020, should immune tolerance induction still be our first option?
Carmen Escuriola-Ettingshausen (Germany)


 

Practical considerations for modern-day management of inhibitors: global considerations for care
Cristina Catarino (Portugal)


 

Prevention and management of thrombosis in haemophilia
Cedric Hermans (Belgium)


 

Getting to the heart of the matter: assessing CV risk in haemophilia
Christophe Beauloye (Belgium)


 

 

 

 

 

PP-HEM-EEP-0025; Datum izrade: lipanj, 2021.